<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To describe the clinical features, treatment and prognosis of acquired thrombotic thrombocytopenic <z:hpo ids='HP_0000979'>purpura</z:hpo> (<z:chebi fb="1" ids="18284">TTP</z:chebi>) in children based on a single institution experience </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: This study is a retrospective review of <z:hpo ids='HP_0000001'>all</z:hpo> 12 children with <z:chebi fb="1" ids="18284">TTP</z:chebi> seen at New York Medical College- Westchester Medical Center during a period of 15 y from 1993 to 2008 </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: There were 7 females and 5 males with acquired <z:chebi fb="1" ids="18284">TTP</z:chebi>, with a median age of 13 (range, 6-17); and no cases of congenital <z:chebi fb="1" ids="18284">TTP</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>The classic pentad of <z:chebi fb="1" ids="18284">TTP</z:chebi> (<z:hpo ids='HP_0001937'>microangiopathic hemolytic anemia</z:hpo>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, neurologic symptoms, <z:hpo ids='HP_0000082'>renal dysfunction</z:hpo> and <z:hpo ids='HP_0001945'>fever</z:hpo>) was seen in only three patients </plain></SENT>
<SENT sid="4" pm="."><plain>Nine had renal involvement; eight had neurologic symptoms; and four had <z:hpo ids='HP_0001945'>fever</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 12 patients had <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, <z:hpo ids='HP_0001903'>anemia</z:hpo>, and elevated LDH </plain></SENT>
<SENT sid="6" pm="."><plain>Nine had idiopathic <z:chebi fb="1" ids="18284">TTP</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Three patients had one of the following underlying disorders: <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, mixed <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disorder</z:e>, and <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (post-bone marrow transplant on <z:chebi fb="0" ids="4031">cyclosporine</z:chebi>) </plain></SENT>
<SENT sid="8" pm="."><plain>ADAMTS13 level was decreased in 7 of 8 patients studied </plain></SENT>
<SENT sid="9" pm="."><plain>Eight of 10 patients achieved remission with plasmapheresis alone </plain></SENT>
<SENT sid="10" pm="."><plain>Two needed additional treatment before achieving remission </plain></SENT>
<SENT sid="11" pm="."><plain>Two had one or more relapses, requiring immunosupressive treatment with vincrisine, <z:chebi fb="0" ids="8382">prednisone</z:chebi>, or rituximab </plain></SENT>
<SENT sid="12" pm="."><plain>The patient with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> died of <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> 5 y after bone marrow transplantation </plain></SENT>
<SENT sid="13" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> other 11 patients are alive and free of <z:chebi fb="1" ids="18284">TTP</z:chebi> for a median follow-up of 12 mo (range, 3-72 mo) </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSIONS: Acquired pediatric <z:chebi fb="1" ids="18284">TTP</z:chebi> responds well to plasmapheresis </plain></SENT>
<SENT sid="15" pm="."><plain>However, many patients do require additional treatment because of refractoriness to plasmapheresis or relapse </plain></SENT>
<SENT sid="16" pm="."><plain>The clinical features, response to treatment, and relapse rate of pediatric <z:chebi fb="1" ids="18284">TTP</z:chebi> appear similar to those of adult <z:chebi fb="1" ids="18284">TTP</z:chebi> </plain></SENT>
</text></document>